Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-08-11
2008-08-12
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S195000
Reexamination Certificate
active
07410988
ABSTRACT:
2-Amido-4-substituted-aryl-thiazole-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, methods of using compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions comprising compounds exhibiting ATP-utilizing enzyme inhibitory activity, are disclosed.
REFERENCES:
patent: 5189049 (1993-02-01), Frehel et al.
patent: 5314889 (1994-05-01), Boigegrain et al.
patent: 5380736 (1995-01-01), Boigegrain et al.
patent: 5670534 (1997-09-01), Animati et al.
patent: 5741796 (1998-04-01), Hartman et al.
patent: 6114365 (2000-09-01), Pevarello et al.
patent: 6242196 (2001-06-01), Spiegelman et al.
patent: 6596746 (2003-07-01), Das et al.
patent: 6696567 (2004-02-01), Blumenkopf et al.
patent: 2004/0053973 (2004-03-01), Ohkawa et al.
patent: 2004/0063946 (2004-04-01), Ohkawa et al.
patent: 2004/0110797 (2004-06-01), Munchhof et al.
patent: 2004/0122016 (2004-06-01), Cao et al.
patent: 2005/0065198 (2005-03-01), Weinstein
patent: 2007/0281919 (2007-06-01), Fontaine et al.
patent: 154190 (1985-02-01), None
patent: 1364949 (2003-11-01), None
patent: 07-149745 (1995-06-01), None
patent: 09-235278 (1997-09-01), None
patent: 10-287634 (1998-10-01), None
patent: 2002-053566 (2002-02-01), None
patent: 2003-053566 (2003-02-01), None
patent: WO 96/16650 (1996-06-01), None
patent: WO 97/24119 (1997-07-01), None
patent: WO 00/62778 (2000-10-01), None
patent: WO 01/10865 (2001-02-01), None
patent: WO 01/23382 (2001-04-01), None
patent: WO 01/46165 (2001-06-01), None
patent: WO 01/74811 (2001-10-01), None
patent: WO01/81298 (2001-11-01), None
patent: WO 02/100433 (2002-12-01), None
patent: WO 02/101007 (2002-12-01), None
patent: WO 03/007945 (2003-01-01), None
patent: WO 03/048140 (2003-06-01), None
patent: WO 03/050090 (2003-06-01), None
patent: WO 03/062215 (2003-07-01), None
patent: WO 03/066630 (2003-08-01), None
patent: WO 2004/002481 (2004-01-01), None
patent: WO 2004/013141 (2004-02-01), None
patent: WO2004/033439 (2004-04-01), None
patent: WO 2004/037250 (2004-05-01), None
patent: WO 2004/041813 (2004-05-01), None
patent: WO 2004041813 (2004-05-01), None
patent: WO2004/058255 (2004-07-01), None
patent: WO 2004/071447 (2004-08-01), None
patent: WO 2005040161 (2005-05-01), None
Patani et al. “Bioisosterism: A Rational Approach to Drug Design” Chemical Reviews, 1996, vol. 96, pp. 3147-3176.
Foster, J. Estelle et al., “Kinetic and mechanistic analyses of new classes of inhibitors of two-component signal transduction systems using a coupled assay containing HpkA-DrrA from Thermotoga maritima,” Microbiology (2004) 150: 885-896.
Miwatashi, Seiji et al., “Synthesis and Biological Activities of 4-Phenyl-5-pyridyl-1,3-thiazole Derivatives as p38 MAP Kinase Inhibitors,” Chem. Pharm. Bull. (2005) 53(4): 410-418.
International Search Report and Written Opinion mailed Jun. 8, 2006, in counterpart PCT Application No. PCT/US05/28549.
Sasho, S. et al., “Preparation and Formulation of Thiazole Derivatives as Cell Adhesion Inhibitors”Database WPI WeekAbstract AN 1997-255535 (JP 09087282)), London:Derwent Publications Ltd.199723 (Mar. 31, 1997).
Chen Ke
Dickson, Jr. John K.
Hodge Carl Nicholas
Mendoza Jose Serafin
Genentech Inc.
Kosack Joseph R.
Saeed Kamal
Walsh Christopher J.
LandOfFree
2-Amido-thiazole-based compounds exhibiting ATP-utilizing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Amido-thiazole-based compounds exhibiting ATP-utilizing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Amido-thiazole-based compounds exhibiting ATP-utilizing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4009386